BMJ  1990;300:297-300 (3 February), doi:10.1136/bmj.300.6720.297

Microalbuminuria as predictor of increased mortality in elderly people.

Department of Medicine, Fredericia Hospital, Denmark.

OBJECTIVE--Correlation of the urinary albumin excretion rate and the risk of death among elderly subjects. DESIGN--216 Subjects aged 60-74 whose urinary albumin excretion rate had been determined were followed up 62-83 months later. SETTING--Municipality of Fredericia, Denmark. SUBJECTS--223 People who had been selected as control subjects for diabetics found during a systematic screening for diabetes of all people aged 60-74 living in the municipality of Fredericia, Denmark. Of these subjects, 216 had an extensive clinical and biochemical examination within a few weeks of selection. MAIN OUTCOME MEASURE--Death. RESULTS--The median urinary albumin excretion rate was 7.52 micrograms/min. Eight of those with a rate below the median died compared with 23 with a rate equal to or greater than the median (p = 0.0078). The median albumin excretion rate in the 31 who died was 15.00 micrograms/min. Cardiovascular disease was the most common cause of death in both groups. A multivariate regression analysis of survival data was performed using the proportional hazards model. Besides albumin excretion rate, male sex, serum creatinine concentration, and hypertension were found to be of prognostic value. CONCLUSIONS--The association between the albumin excretion rate and mortality that has been described in recent years in patients with diabetes mellitus may be present in elderly people in general, even when other known risk factors are taken into account.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Mikkelsen, M. M., Andersen, N. H., Christensen, T. D., Hansen, T. K., Eiskjaer, H., Mogensen, C. E., Hjortdal, V. E., Johnsen, S. P. (2009). Microalbuminuria and short-term prognosis in patients undergoing cardiac surgery. ICVTS 9: 484-490 [Abstract] [Full text]  
• Perico, N., Bravo, R. F., De Leon, F. R., Remuzzi, G. (2009). Screening for chronic kidney disease in emerging countries: feasibility and hurdles. Nephrol Dial Transplant 24: 1355-1358 [Full text]  
• Baekken, M., Os, I., Sandvik, L., Oektedalen, O. (2008). Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population. Nephrol Dial Transplant 23: 3130-3137 [Abstract] [Full text]  
• Forman, J. P., Fisher, N. D.L., Schopick, E. L., Curhan, G. C. (2008). Higher Levels of Albuminuria within the Normal Range Predict Incident Hypertension. J. Am. Soc. Nephrol. 19: 1983-1988 [Abstract] [Full text]  
• Magliano, D. J., Polkinghorne, K. R., Barr, E. L.M., Su, Q., Chadban, S. J., Zimmet, P. Z., Shaw, J. E., Atkins, R. C. (2007). HPLC-Detected Albuminuria Predicts Mortality. J. Am. Soc. Nephrol. 18: 3171-3176 [Abstract] [Full text]  
• Hirai, F. E., Moss, S. E., Knudtson, M. D., Klein, B. E. K., Klein, R. (2007). Retinopathy and Survival in a Population without Diabetes: The Beaver Dam Eye Study. Am J Epidemiol 166: 724-730 [Abstract] [Full text]  
• Daly, C. (2007). Is early chronic kidney disease an important risk factor for cardiovascular disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease. Nephrol Dial Transplant 22: ix19-ix25 [Full text]  
• Florvall, G., Basu, S., Larsson, A. (2006). Apolipoprotein A1 Is a Stronger Prognostic Marker Than Are HDL and LDL Cholesterol for Cardiovascular Disease and Mortality in Elderly Men. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61: 1262-1266 [Abstract] [Full text]  
• Redon, J., Morales-Olivas, F., Galgo, A., Brito, M. A., Mediavilla, J., Marin, R., Rodriguez, P., Tranche, S., Lozano, J. V., Filozof, C., and the MAGAL Group, (2006). Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension. J. Am. Soc. Nephrol. 17: S236-S245 [Abstract] [Full text]  
• van de Wal, R. M.A., Gansevoort, R. T., van der Harst, P., Boomsma, F., Thijs Plokker, H.W., van Veldhuisen, D. J., de Jong, P. E., van Gilst, W. H., Voors, A. A. (2006). Predictors of Angiotensin-Converting Enzyme Inhibitor-Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients. Hypertension 48: 870-876 [Abstract] [Full text]  
• Sarafidis, P. A., Bakris, G. L. (2006). Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant 21: 2366-2374 [Full text]  
• de Jong, P. E., Curhan, G. C. (2006). Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives. J. Am. Soc. Nephrol. 17: 2120-2126 [Abstract] [Full text]  
• Tonelli, M., Jose, P., Curhan, G., Sacks, F., Braunwald, E., Pfeffer, M., Cholesterol and Recurrent Events (CARE) Trial Inve, (2006). Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 332: 1426- [Abstract] [Full text]  
• Tsakiris, A., Doumas, M., Lagatouras, D., Vyssoulis, G., Karpanou, E., Nearchou, N., Kouremenou, C., Skoufas, P. (2006). Microalbuminuria Is Determined by Systolic and Pulse Pressure Over a 12-Year Period and Related to Peripheral Artery Disease in Normotensive and Hypertensive Subjects: The Three Areas Study in Greece (TAS-GR). ANGIOLOGY 57: 313-320 [Abstract]  
• Madison, J. R., Spies, C., Schatz, I. J., Masaki, K., Chen, R., Yano, K., Curb, J. D. (2006). Proteinuria and Risk for Stroke and Coronary Heart Disease During 27 Years of Follow-up: The Honolulu Heart Program.. Arch Intern Med 166: 884-889 [Abstract] [Full text]  
• Segura, J., Garcia-Donaire, J. A., Praga, M., Ruilope, L. M. (2006). Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients. J. Am. Soc. Nephrol. 17: S136-S140 [Abstract] [Full text]  
• Swift, P. A., Markandu, N. D., Sagnella, G. A., He, F. J., MacGregor, G. A. (2005). Modest Salt Reduction Reduces Blood Pressure and Urine Protein Excretion in Black Hypertensives: A Randomized Control Trial. Hypertension 46: 308-312 [Abstract] [Full text]  
• Redon, J. (2005). Urinary Albumin Excretion: Lowering the Threshold of Risk in Hypertension. Hypertension 46: 19-20 [Full text]  
• Klausen, K. P., Scharling, H., Jensen, G., Jensen, J. S. (2005). New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death. Hypertension 46: 33-37 [Abstract] [Full text]  
• Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., Lameire, N., for the European Uremic Toxin Work Group (EUTox), (2005). Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20: 1048-1056 [Abstract] [Full text]  
• Pascual, J. M., Rodilla, E., Gonzalez, C., Perez-Hoyos, S., Redon, J. (2005). Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension. Hypertension 45: 1125-1130 [Abstract] [Full text]  
• Kistorp, C., Raymond, I., Pedersen, F., Gustafsson, F., Faber, J., Hildebrandt, P. (2005). N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults. JAMA 293: 1609-1616 [Abstract] [Full text]  
• Furtner, M., Kiechl, S., Mair, A., Seppi, K., Weger, S., Oberhollenzer, F., Poewe, W., Willeit, J. (2005). Urinary albumin excretion is independently associated with carotid and femoral artery atherosclerosis in the general population. Eur Heart J 26: 279-287 [Abstract] [Full text]  
• Asselbergs, F. W., Diercks, G. F.H., Hillege, H. L., van Boven, A. J., Janssen, W. M.T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., van Gilst, W. H., for the Prevention of Renal and Vascular Endstage, (2004). Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria. Circulation 110: 2809-2816 [Abstract] [Full text]  
• Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., Hsu, C.-y. (2004). Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. NEJM 351: 1296-1305 [Abstract] [Full text]  
• Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., Jensen, J. S. (2004). Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes. Circulation 110: 32-35 [Abstract] [Full text]  
• Jensen, J. S., Feldt-Rasmussen, B., Jensen, K. S., Clausen, P., Scharling, H., Nordestgaard, B. G. (2004). Transendothelial lipoprotein exchange and microalbuminuria. Cardiovasc Res 63: 149-154 [Abstract] [Full text]  
• Yuyun, M. F., Khaw, K.-T., Luben, R., Welch, A., Bingham, S., Day, N. E., Wareham, N. J. (2004). A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study. Am J Epidemiol 159: 284-293 [Abstract] [Full text]  
• Yuyun, M. F, Khaw, K.-T., Luben, R., Welch, A., Bingham, S., Day, N. E, Wareham, N. J (2004). Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 33: 189-198 [Abstract] [Full text]  
• Wachtell, K., Ibsen, H., Olsen, M. H., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlof, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristianson, K., Lederballe-Pedersen, O., Nieminen, M. S., Okin, P. M., Omvik, P., Oparil, S., Wedel, H., Snapinn, S. M., Aurup, P. (2003). Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study. ANN INTERN MED 139: 901-906 [Abstract] [Full text]  
• Salmasi, A.-M., Jepson, E., Grenfell, A., Kirollos, C., Dancy, M. (2003). The Degree of Albuminuria Is Related to Left Ventricular Hypertrophy in Hypertensive Diabetics and Is Associated with Abnormal Left Ventricular Filling: A Pilot Study. ANGIOLOGY 54: 671-678 [Abstract]  
• Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., Wilson, P. W. (2003). Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42: 1050-1065 [Full text]  
• Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., Wilson, P. W. (2003). Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169 [Full text]  
• Atkins, R. C., Briganti, E. M., Zimmet, P. Z., Chadban, S. J. (2003). Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant 18: 2170-2174 [Abstract] [Full text]  
• White, W. B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J., Weber, M. A. (2003). Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension. Hypertension 41: 1021-1026 [Abstract] [Full text]  
• Diercks, G. F. H., Hillege, H. L., van Boven, A. d J., Kors, J. A., Crijns, H. J. G. M., Grobbee, D. E., de Jong, P. E., van Gilst, W. H. (2002). Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes. J Am Coll Cardiol 40: 1401-1407 [Abstract] [Full text]  
• Hillege, H. L., Fidler, V., Diercks, G. F.H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O.B., Janssen, W. M.T., Grobbee, D. E., de Jong, P. E., for the Prevention of Renal and Vascular End Stage, (2002). Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population. Circulation 106: 1777-1782 [Abstract] [Full text]  
• Redon, J., Rovira, E., Miralles, A., Julve, R., Pascual, J. M. (2002). Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension. Hypertension 39: 794-798 [Abstract] [Full text]  
• Garg, J. P, Bakris, G. L (2002). Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med 7: 35-43 [Abstract]  
• Pedrinelli, R., Dell'Omo, G., Penno, G., Mariani, M. (2001). Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc Med 6: 257-264 [Abstract]  
• Shlipak, M. G., Simon, J. A., Grady, D., Lin, F., Wenger, N. K., Furberg, C. D., for the Heart and Estrogen/progestin Replacement S, (2001). Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38: 705-711 [Abstract] [Full text]  
• Gerstein, H. C., Mann, J. F. E., Yi, Q., Zinman, B., Dinneen, S. F., Hoogwerf, B., Halle, J. P., Young, J., Rashkow, A., Joyce, C., Nawaz, S., Yusuf, S., for the HOPE Study Investigators, (2001). Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals. JAMA 286: 421-426 [Abstract] [Full text]  
• Di Bello, V., Pedrinelli, R., Giorgi, D., Bertini, A., Caputo, M. T., Cioppi, A., Talini, E., Leonardo, M., Dell'Omo, G., Paterni, M., Giusti, C. (2001). Microalbuminuria, Pulse Pressure, Left Ventricular Hypertrophy, and Myocardial Ultrasonic Tissue Characterization In Essential Hypertension. ANGIOLOGY 52: 175-183 [Abstract]  
• Viberti, G.C., Thomas, S.M. (2000). Searching for new coronary heart disease risk factors. Eur Heart J 21: 1905-1906  
• Diercks, G.F.H, van Boven, A.J, Hillege, H.L, Janssen, W.M.T, Kors, J.A, de Jong, P.E, Grobbee, D.E, Crijns, H.J.G.M, van Gilst, W.H (2000). Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 21: 1922-1927 [Abstract]  
• Agewall, S., Fagerberg, B. (1996). Risk Factors That Predict Development of Microalbuminuria in Treated Hypertensive Men. ANGIOLOGY 47: 963-972 [Abstract]  

Online poll

Find out more here>> and here>>